FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
Go back to FDA accepts Cingulate's drug application for ADHD treatment CTx-1301| (NASDAQ: CING) | Delayed: 4.78 -0.05 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.83 | 52 Week High | $ | |||
| Open | $4.80 | 52 Week Low | $ | |||
| Day High | $4.95 | P/E | N/A | |||
| Day Low | $4.67 | EPS | $ | |||
| Volume | 176,450 | |||||
| (NASDAQ: CINGW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 2,622 | |||||
